Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy
- 1 March 1999
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 137 (1) , 91-98
- https://doi.org/10.1016/s0304-3835(98)00349-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatmentJournal of Photochemistry and Photobiology B: Biology, 1998
- Inhibition of tumor growth by elimination of granulocytes.The Journal of Experimental Medicine, 1995
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- Interleukin 7 induces CD4+ T cell-dependent tumor rejection.The Journal of Experimental Medicine, 1991
- Urinary cytokines following photodynamic therapy for bladder cancer a preliminary reportUrology, 1990
- Effect of Photodynamic Therapy on Tumor Necrosis Factor Production by Murine MacrophagesJNCI Journal of the National Cancer Institute, 1990
- Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.The Journal of Experimental Medicine, 1984
- Cloned T Lymphocytes and Monoclonal Antibodies as Probes for Cell Surface Molecules Active in T Cell‐Mediated CytolysisImmunological Reviews, 1982
- Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibodyImmunogenetics, 1982
- B220: a B cell-specific member of the T200 glycoprotein familyNature, 1981